Adept Chemical Inc. Custom Case Solution & Analysis

1. Evidence Brief — Business Case Data Researcher

Financial Metrics

• Operating Profit Margin: Declined from 14% to 8.2% over the last 3 fiscal years (Exhibit 1).
• Revenue Growth: Stagnant at 1.2% CAGR despite a 4.5% industry average growth (Exhibit 2).
• Debt-to-Equity Ratio: 1.8x, significantly higher than the industry median of 1.1x (Exhibit 3).
• R&D Spend: 3.5% of revenue, down from 5.8% five years ago (Paragraph 14).

Operational Facts

• Manufacturing Capacity: Three plants operating at 62% utilization (Paragraph 22).
• Headcount: 1,400 employees; 60% are legacy production roles (Exhibit 4).
• Supply Chain: 85% of raw materials sourced from two suppliers in Southeast Asia (Paragraph 28).

Stakeholder Positions

• CEO (Marcus Thorne): Favors aggressive acquisition to regain market share.
• CFO (Elena Rodriguez): Prioritizes debt reduction and operational efficiency.
• Board of Directors: Concerned about dividend sustainability and share price volatility.

Information Gaps

• Customer churn rate by segment is unavailable.
• Specific terms of the existing credit facility covenants are not disclosed.

2. Strategic Analysis — Market Strategy Consultant

Core Strategic Question

• How can Adept Chemical recover market share while managing a restrictive balance sheet?

Structural Analysis

• Porter Five Forces: High supplier concentration creates a bottleneck in input pricing. Buyer power is increasing as legacy products become commoditized.
• Value Chain: The company is trapped in mid-tier production with high overhead, failing to compete on cost or innovation.

Strategic Options

• Option 1: Divestment of Underperforming Plants. Sell the two lowest-utilization facilities to pay down debt and fund targeted R&D. Trade-off: Immediate revenue loss vs. improved margin profile.
• Option 2: Aggressive M&A. Borrow to acquire a smaller, high-growth competitor. Trade-off: Potential for scale vs. extreme risk of insolvency if integration fails.
• Option 3: Operational Turnaround. Focus on internal automation and supply chain diversification. Trade-off: Low capital requirement vs. slow time-to-market.

Preliminary Recommendation

Option 1 is the preferred path. The company cannot afford the debt service of Option 2, and Option 3 lacks the urgency required to stop the slide in share price.

3. Implementation Roadmap — Operations and Implementation Planner

Critical Path

• Month 1-3: Conduct due diligence on plant divestment and secure buyer interest.
• Month 4-6: Execute asset sale and apply proceeds to high-interest debt tranches.
• Month 7-12: Reallocate remaining capacity to high-margin specialty chemicals.

Key Constraints

• Workforce Union Agreements: Restructuring production may trigger labor disputes.
• Regulatory Compliance: Environmental remediation costs associated with plant closures are currently unquantified.

Risk-Adjusted Implementation

The plan assumes a 15% discount on book value for rapid divestment. If the market for industrial assets softens, the firm must pivot to a sale-leaseback model to maintain liquidity.

4. Executive Review and BLUF — Senior Partner

BLUF

Adept Chemical is dying because it is neither a low-cost producer nor a specialty innovator. The current strategy of holding legacy assets while hoping for organic growth is terminal. The management team must stop debating acquisitions and start liquidating non-core assets. Divestment is the only mechanism to repair the balance sheet and provide the liquidity required to pivot to specialty chemicals. If the CEO cannot commit to a 25% reduction in production footprint within 12 months, the board should replace him. The company has no room for half-measures.

Dangerous Assumption

The assumption that the firm can successfully transition to specialty chemicals without a total overhaul of the current sales force, which is trained only for commodity chemical distribution.

Unaddressed Risks

• Supplier Retaliation: Reducing production volume may trigger price hikes from the two dominant suppliers.
• Talent Flight: The most capable technical staff will likely depart during the uncertainty of a plant divestment.

Unconsidered Alternative

A joint venture with a specialty chemical manufacturer, providing access to their distribution network in exchange for exclusive supply of Adept’s remaining commodity output.

Verdict: APPROVED FOR LEADERSHIP REVIEW